| 1 | Neoplasms, Neuroepithelial | 32% |
| 2 | Gliomatosis cerebri | 32% |
| 3 | Medulloblastoma | 31.5% |
| 4 | Neuroectodermal Tumors | 30.5% |
| 5 | melanoma | 29.8% |
| 6 | leukemia | 27.9% |
| 7 | Neoplasms, Germ Cell and Embryonal | 27.9% |
| 8 | Neoplasms, Glandular and Epithelial | 27.9% |
| 9 | Germ Cell Cancer | 27.9% |
| 10 | Carcinosarcoma | 27.7% |
| 11 | Hemangiosarcoma | 27.7% |
| 12 | lymphangiosarcoma | 27.7% |
| 13 | Adenoma, Acidophil | 27.6% |
| 14 | Ganglioneuroma | 27.6% |
| 15 | Glioma | 27.6% |
| 16 | Malignant Glioma | 27.6% |
| 17 | Carcinoid Tumor | 26.6% |
| 18 | Neurilemmoma | 26.6% |
| 19 | Hutchinson's Melanotic Freckle | 26.6% |
| 20 | Melanoma, Amelanotic | 26.6% |
| 21 | Astrocytoma | 25.5% |
| 22 | Ependymoma | 25.5% |
| 23 | oligodendroglioma | 25.5% |
| 24 | Ganglioglioma | 25.5% |
| 25 | gliosarcoma | 25.5% |
| 26 | Anaplastic astrocytoma | 25.5% |
| 27 | Anaplastic Oligodendroglioma | 25.5% |
| 28 | Basal cell carcinoma | 25% |
| 29 | Carcinoma, Papillary | 25% |
| 30 | Squamous cell carcinoma | 25% |
| 31 | Chondrosarcoma | 25% |
| 32 | Craniopharyngioma | 25% |
| 33 | Cystadenoma | 25% |
| 34 | leiomyosarcoma | 25% |
| 35 | liposarcoma | 25% |
| 36 | Mesothelioma | 25% |
| 37 | synovial sarcoma | 25% |
| 38 | Neuroectodermal Tumor, Melanotic | 25% |
| 39 | Angiomyolipoma | 25% |
| 40 | Clear Cell Sarcoma of Soft Tissue | 25% |
| 41 | Alveolar Soft Part Sarcoma | 25% |
| 42 | Neuroendocrine Tumors | 25% |
| 43 | Composite Lymphoma | 25% |
| 44 | Sarcoma, Myeloid | 25% |
| 45 | Carcinoma, Basal Cell | 25% |
| 46 | Malignant Carcinoid Syndrome | 25% |
| 47 | Lymphoma | 24.7% |
| 48 | Carcinoma 256, Walker | 24.6% |
| 49 | Glioblastoma | 24.4% |
| 50 | Neuroblastoma | 24.4% |
| 51 | Glioblastoma Multiforme | 24.4% |
| 52 | Ganglioneuroblastoma | 23.9% |
| 53 | Histiocytosis, Langerhans-Cell | 23.7% |
| 54 | Cystadenocarcinoma | 23.7% |
| 55 | Fibrosarcoma | 23.7% |
| 56 | Osteosarcoma | 23.7% |
| 57 | Mucoepidermoid Carcinoma | 23.7% |
| 58 | Lymphohistiocytosis, Hemophagocytic | 23.6% |
| 59 | Erdheim-Chester Disease | 23.6% |
| 60 | Thymoma | 23.5% |
| 61 | Adenofibroma | 23% |
| 62 | Fibroadenoma | 23% |
| 63 | Malignant Fibrous Histiocytoma | 23% |
| 64 | Melanoma, Experimental | 22.9% |
| 65 | Lymphocele | 22.8% |
| 66 | Meningioma | 22.4% |
| 67 | Bowen's Disease | 22.3% |
| 68 | Paraganglioma | 22.3% |
| 69 | Rhabdomyosarcoma | 22.3% |
| 70 | Giant Cell Tumor of Bone | 22.3% |
| 71 | Leukemia, Plasma Cell | 22% |
| 72 | Dermatofibrosarcoma | 21.6% |
| 73 | Dermatofibrosarcoma Protuberans | 21.6% |
| 74 | Lymphangioleiomyomatosis | 21.4% |
| 75 | Pheochromocytoma | 21% |
| 76 | Alveolar rhabdomyosarcoma | 21% |
| 77 | Adenitis | 20.9% |
| 78 | Lymphadenitis | 20.9% |
| 79 | Lymphangitis | 20.9% |
| 80 | Lymphedema | 20.9% |
| 81 | Splenic Diseases | 20.9% |
| 82 | Thymus Hyperplasia | 20.9% |
| 83 | Pseudolymphoma | 20.9% |
| 84 | Lymphadenopathy | 20.9% |
| 85 | Thymus Neoplasms | 20.7% |
| 86 | Adenoma | 20.5% |
| 87 | Ameloblastoma | 20.5% |
| 88 | Angiokeratoma | 20.5% |
| 89 | Carcinoma | 20.5% |
| 90 | Chordoma | 20.5% |
| 91 | Hemangioma | 20.5% |
| 92 | hemangiopericytoma | 20.5% |
| 93 | Lymphangioma | 20.5% |
| 94 | Mesenchymoma | 20.5% |
| 95 | Nevus | 20.5% |
| 96 | Teratoma | 20.5% |
| 97 | Hepatoblastoma | 20.5% |
| 98 | Mixed Tumor, Mullerian | 20.5% |
| 99 | Germinoma | 20.5% |
| 100 | Teratocarcinoma | 20.5% |
| 101 | Angiofibroma | 20.5% |
| 102 | Sarcoma | 20.5% |
| 103 | Epithelioma | 20.5% |
| 104 | Carcinoid Heart Disease | 20.4% |
| 105 | Carcinoma, Ehrlich Tumor | 19.7% |
| 106 | Dermoid Cyst | 19.7% |
| 107 | Carcinoma, Lewis Lung | 19.7% |
| 108 | Choriocarcinoma | 19% |
| 109 | Carcinoma, Lobular | 19% |
| 110 | Neurofibrosarcoma | 18.4% |
| 111 | Hodgkin Disease | 18% |
| 112 | Lymphoma, Non-Hodgkin | 18% |
| 113 | Trophoblastic Neoplasms | 17.8% |
| 114 | Leukemia, Experimental | 17.7% |
| 115 | Leukemia L1210 | 17.6% |
| 116 | Leukemia P388 | 17.6% |
| 117 | Acanthoma | 17.6% |
| 118 | Retinoblastoma | 17.3% |
| 119 | Splenic Neoplasms | 17.2% |
| 120 | Endometrial Stromal Sarcoma | 17.2% |
| 121 | Adenocarcinoma | 16.9% |
| 122 | Carcinoma in Situ | 16.9% |
| 123 | Carcinoma, Transitional Cell | 16.9% |
| 124 | Phyllodes Tumor | 16.9% |
| 125 | Dysgerminoma | 16.9% |
| 126 | Hemangioendothelioma | 16.9% |
| 127 | Lipoma | 16.9% |
| 128 | Myoma | 16.9% |
| 129 | Myxoma | 16.9% |
| 130 | Neuroma | 16.9% |
| 131 | Papilloma | 16.9% |
| 132 | Pseudomyxoma Peritonei | 16.9% |
| 133 | Seminoma | 16.9% |
| 134 | Papillomatosis | 16.9% |
| 135 | Angiolipoma | 16.9% |
| 136 | Myelolipoma | 16.9% |
| 137 | Neoplasms, Bone Tissue | 16.9% |
| 138 | Neoplasms, Fibrous Tissue | 16.9% |
| 139 | Smooth Muscle Tumor | 16.9% |
| 140 | Adenomatosis, Pulmonary | 16.9% |
| 141 | Adenomatous Polyps | 16.9% |
| 142 | Carcinoma, Large Cell | 16.9% |
| 143 | Carcinoma, Small Cell | 16.9% |
| 144 | Desmoplastic Small Round Cell Tumor | 16.9% |
| 145 | Chondroma | 16.9% |
| 146 | Enchondroma | 16.9% |
| 147 | Sarcoma 180 | 16.3% |
| 148 | Lymphangiectasis, Intestinal | 16.2% |
| 149 | Leukemia, T-Cell | 15.9% |
| 150 | Leukemia, B-Cell | 15.9% |
| 151 | Lymphoproliferative Disorders | 15.8% |
| 152 | Lymphatic Abnormalities | 15.8% |
| 153 | Lymphomatoid Granulomatosis | 15.6% |
| 154 | Sarcoma, Experimental | 15.5% |
| 155 | Plasmacytoma | 15.3% |
| 156 | Adenoid Cystic Carcinoma | 15.1% |
| 157 | fibroma | 15.1% |
| 158 | Fibromatosis | 15.1% |
| 159 | Osteoblastoma | 15.1% |
| 160 | Osteoma | 15.1% |
| 161 | Rhabdomyoma | 15.1% |
| 162 | Chondromatosis | 15.1% |
| 163 | Adenocarcinoma, Clear Cell | 15.1% |
| 164 | Cholangiocarcinoma | 15.1% |
| 165 | Cervical Intraepithelial Neoplasia | 15.1% |
| 166 | Hemangioblastoma | 15.1% |
| 167 | Lymphoma, Extranodal NK-T-Cell | 15.1% |
| 168 | Leukemia, Myelomonocytic, Chronic | 15% |
| 169 | Waldenstrom Macroglobulinemia | 15% |
| 170 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 15% |
| 171 | Leukemia, Radiation-Induced | 14.9% |
| 172 | Lymphoma, Follicular | 14.8% |
| 173 | T-Cell Lymphoma | 14.8% |
| 174 | Mantle cell lymphoma | 14.8% |
| 175 | Hamartoma | 14.6% |
| 176 | Neoplasms, Hormone-Dependent | 14.6% |
| 177 | Neoplasms, Multiple Primary | 14.6% |
| 178 | Paraneoplastic Syndromes | 14.6% |
| 179 | Precancerous Conditions | 14.6% |
| 180 | Neoplasms, Second Primary | 14.6% |
| 181 | Sezary Syndrome | 14.6% |
| 182 | Acoustic Neuroma | 14.3% |
| 183 | Fibromatosis, Aggressive | 14.2% |
| 184 | Fibromatosis, Abdominal | 14.2% |
| 185 | Klatskin Tumor | 14.2% |
| 186 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 13.8% |
| 187 | Leukemia, Large Granular Lymphocytic | 13.8% |
| 188 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 13.8% |
| 189 | Elephantiasis | 13.6% |
| 190 | Hypersplenism | 13.6% |
| 191 | Sarcoidosis | 13.6% |
| 192 | Elephantiasis Nostras Verrucosa | 13.6% |
| 193 | Carcinoma, Pancreatic Ductal | 13.3% |
| 194 | Lymphoma, T-Cell, Cutaneous | 13.2% |
| 195 | Lymphoma, AIDS-Related | 13.2% |
| 196 | Enteropathy-Associated T-Cell Lymphoma | 13.2% |
| 197 | Primary Effusion Lymphoma | 13.2% |
| 198 | Leukemia, Myeloid, Chronic-Phase | 13.2% |
| 199 | Optic Nerve Glioma | 12.9% |
| 200 | Mycosis Fungoides | 12.5% |
| 201 | Lymphomatoid Papulosis | 12.5% |
| 202 | Plasmablastic lymphoma | 12.5% |
| 203 | Vipoma | 12.4% |
| 204 | Mucocutaneous Lymph Node Syndrome | 12.3% |
| 205 | Hematologic Neoplasms | 12.3% |
| 206 | Hydatidiform Mole | 12.2% |
| 207 | Hemangioma, Cavernous | 12% |
| 208 | Basal Cell Nevus Syndrome | 11.9% |
| 209 | Eosinophilic Granuloma | 11.5% |
| 210 | Mastocytoma | 11.3% |
| 211 | Mastocytosis, Systemic | 11.2% |
| 212 | Hepatocellular Adenoma | 11.1% |
| 213 | Agammaglobulinemia | 11% |
| 214 | Cyst | 10.9% |
| 215 | Neoplastic Processes | 10.9% |
| 216 | Neoplastic Syndromes, Hereditary | 10.9% |
| 217 | Pregnancy Complications, Neoplastic | 10.9% |
| 218 | Multiple Endocrine Neoplasia | 10.9% |
| 219 | Neoplasms, Experimental | 10.7% |
| 220 | Granuloma | 10.3% |
| 221 | Splenic Infarction | 10.3% |
| 222 | Mastocytosis | 10.2% |
| 223 | Sturge-Weber Syndrome | 10.2% |
| 224 | Tumor Lysis Syndrome | 10.2% |
| 225 | Nephroblastoma | 10.1% |
| 226 | Heavy Chain Disease | 10.1% |
| 227 | Gastrointestinal Stromal Tumors | 10.1% |
| 228 | Primary amyloidosis | 10.1% |
| 229 | Multiple Myeloma | 10% |
| 230 | neurofibroma | 9.9% |
| 231 | Paraneoplastic Encephalomyelitis | 9.7% |
| 232 | Mammary Neoplasms, Experimental | 9.5% |
| 233 | Burkitt Lymphoma | 9.5% |
| 234 | Bone Marrow Neoplasms | 9.5% |
| 235 | Prolactinoma | 9.4% |
| 236 | Growth Hormone-Secreting Pituitary Adenoma | 9.4% |
| 237 | Abdominal Neoplasms | 9.3% |
| 238 | Erythroplasia | 9.3% |
| 239 | Follicular cyst | 9.3% |
| 240 | Head and Neck Neoplasms | 9.3% |
| 241 | Mucocele | 9.3% |
| 242 | Pilonidal Cyst | 9.3% |
| 243 | Soft Tissue Neoplasms | 9.3% |
| 244 | Thoracic Neoplasms | 9.3% |
| 245 | Thyroglossal Cyst | 9.3% |
| 246 | Synovial Cyst | 9.3% |
| 247 | Aberrant Crypt Foci | 9.3% |
| 248 | Mesoblastic Nephroma | 9.2% |
| 249 | insulinoma | 9.2% |
| 250 | Infectious Mononucleosis | 8.9% |
| 251 | Gastrinoma | 8.9% |
| 252 | Glucagonoma | 8.9% |
| 253 | Dupuytren Contracture | 8.6% |
| 254 | Neoplasms, Radiation-Induced | 8.5% |
| 255 | Urticaria Pigmentosa | 8.5% |
| 256 | Adrenocortical carcinoma | 8.4% |
| 257 | Splenic Rupture | 8.3% |
| 258 | granulosa cell tumor | 8.2% |
| 259 | Carcinoma, Ovarian Epithelial | 8.2% |
| 260 | Disseminated Intravascular Coagulation | 8.1% |
| 261 | Protein S Deficiency | 8.1% |
| 262 | Multiple Endocrine Neoplasia Type 1 | 8.1% |
| 263 | Leydig Cell Tumor | 8% |
| 264 | Polycythemia Vera | 7.7% |
| 265 | Adenomatous Polyposis Coli | 7.7% |
| 266 | Sarcoidosis, Pulmonary | 7.6% |
| 267 | Thrombocythemia, Essential | 7.5% |
| 268 | Tuberous Sclerosis | 7.4% |
| 269 | Renal Cell Carcinoma | 7.3% |
| 270 | Papillary Renal Cell Carcinoma | 7.3% |
| 271 | Digestive System Neoplasms | 7.3% |
| 272 | Endocrine Gland Neoplasms | 7.3% |
| 273 | Eye Neoplasms | 7.3% |
| 274 | Nervous System Neoplasms | 7.3% |
| 275 | Carcinoma, Endometrioid | 7.2% |
| 276 | Bone neoplasms | 7% |
| 277 | Leukoplakia | 7% |
| 278 | Pancreatic Cyst | 7% |
| 279 | Skin Neoplasms | 7% |
| 280 | Nasopharyngeal carcinoma | 7% |
| 281 | Anemia | 7% |
| 282 | Blood Coagulation Disorders | 7% |
| 283 | Blood Platelet Disorders | 7% |
| 284 | Bone Marrow Diseases | 7% |
| 285 | Hemorrhagic Disorders | 7% |
| 286 | Leukocyte Disorders | 7% |
| 287 | Methemoglobinemia | 7% |
| 288 | Pancytopenia | 7% |
| 289 | Polycythemia | 7% |
| 290 | Sulfhemoglobinemia | 7% |
| 291 | Thrombophilia | 7% |
| 292 | Erythrocytosis | 7% |
| 293 | Barrett Esophagus | 6.9% |
| 294 | Breast Cyst | 6.9% |
| 295 | Actinic keratosis | 6.9% |
| 296 | Mediastinal Cyst | 6.9% |
| 297 | Neoplasm Invasiveness | 6.9% |
| 298 | Neoplasm Metastasis | 6.9% |
| 299 | Neoplasm Recurrence, Local | 6.9% |
| 300 | Parathyroid Neoplasms | 6.9% |
| 301 | Parovarian Cyst | 6.9% |
| 302 | Pericardial Cyst | 6.9% |
| 303 | Peritoneal Neoplasms | 6.9% |
| 304 | Thymic Cyst | 6.9% |
| 305 | Thyroid Neoplasm | 6.9% |
| 306 | Thyroid carcinoma | 6.9% |
| 307 | Carcinogenesis | 6.9% |
| 308 | Myxoid cyst | 6.9% |
| 309 | Autoimmune Lymphoproliferative Syndrome | 6.9% |
| 310 | Metastasis | 6.9% |
| 311 | Retroperitoneal Neoplasms | 6.8% |
| 312 | Tracheal Neoplasms | 6.3% |
| 313 | Liver Neoplasms, Experimental | 6.2% |
| 314 | Leukoplakia, Oral | 6.1% |
| 315 | Thrombasthenia | 6.1% |
| 316 | Antithrombin III Deficiency | 6.1% |
| 317 | Protein C Deficiency | 6.1% |
| 318 | Paraneoplastic Cerebellar Degeneration | 6.1% |
| 319 | Splenosis | 6% |
| 320 | Pancreatic Neoplasm | 5.9% |
| 321 | Thrombocytosis | 5.9% |
| 322 | Denys-Drash Syndrome | 5.8% |
| 323 | Afibrinogenemia | 5.6% |
| 324 | Factor VII Deficiency | 5.6% |
| 325 | Factor X Deficiency | 5.6% |
| 326 | Factor XII Deficiency | 5.6% |
| 327 | Hemophilia A | 5.6% |
| 328 | Thyroid Nodule | 5.6% |
| 329 | Activated Protein C Resistance | 5.6% |
| 330 | Factor II deficiency | 5.6% |
| 331 | Factor VIII Deficiency | 5.6% |
| 332 | Factor V deficiency | 5.6% |
| 333 | Factor XI Deficiency | 5.6% |
| 334 | Hypoprothrombinemias | 5.6% |
| 335 | Transfusion Reaction | 5.5% |
| 336 | Hypotensive Transfusion Reaction | 5.5% |
| 337 | Corpus Luteum Cyst | 5.4% |
| 338 | Ovarian Cysts | 5.4% |
| 339 | Vitamin K Deficiency | 5.4% |
| 340 | Esophageal Neoplasms | 5.3% |
| 341 | Pregnancy Complications, Hematologic | 5.3% |
| 342 | Limbic Encephalitis | 5.2% |
| 343 | Mouth Neoplasms | 5.2% |
| 344 | Central Nervous System Neoplasms | 5.2% |
| 345 | Vascular Neoplasms | 5.2% |
| 346 | Genital Neoplasms, Female | 5.1% |
| 347 | Pancreatic Pseudocyst | 5.1% |
| 348 | Lymphatic Metastasis | 5% |
| 349 | Neoplasms, Unknown Primary | 5% |
| 350 | Leukemic Infiltration | 5% |
| 351 | Breast Neoplasms, Male | 5% |
| 352 | Neoplasm Micrometastasis | 5% |
| 353 | Triple Negative Breast Neoplasms | 5% |
| 354 | Hemoglobinuria, Paroxysmal | 5% |
| 355 | Leukemoid Reaction | 5% |
| 356 | Niemann-Pick Disease, Type C | 4.7% |
| 357 | Lambert-Eaton Myasthenic Syndrome | 4.6% |
| 358 | Testicular Neoplasms | 4.6% |
| 359 | Choledochal Cyst | 4.6% |
| 360 | Anemia, Hemolytic | 4.5% |
| 361 | Anemia, Macrocytic | 4.5% |
| 362 | Eosinophilia | 4.5% |
| 363 | Hypoproteinemia | 4.5% |
| 364 | Leukopenia | 4.5% |
| 365 | Thrombocytopenia | 4.5% |
| 366 | Leukostasis | 4.5% |
| 367 | MYELODYSPLASTIC SYNDROME | 4.5% |
| 368 | Peutz-Jeghers Syndrome | 4.5% |
| 369 | Anemia, Diamond-Blackfan | 4.4% |
| 370 | Meningeal Neoplasms | 4.2% |
| 371 | Adrenal Gland Neoplasms | 4.2% |
| 372 | Gastrointestinal Neoplasms | 4.2% |
| 373 | Genital Neoplasms, Male | 4.2% |
| 374 | Liver neoplasms | 4.2% |
| 375 | Uveal Neoplasms | 4.2% |
| 376 | Urologic Neoplasms | 4.1% |
| 377 | Opsoclonus-Myoclonus Syndrome | 4.1% |
| 378 | Purpura, Thrombotic Thrombocytopenic | 4.1% |
| 379 | Sebaceous Gland Neoplasms | 4.1% |
| 380 | Spinal Neoplasms | 4.1% |
| 381 | Polycystic Ovary Syndrome | 4% |
| 382 | Wiskott-Aldrich Syndrome | 4% |
| 383 | Palatal Neoplasms | 3.9% |
| 384 | Nose Neoplasms | 3.8% |
| 385 | Meningeal Carcinomatosis | 3.7% |
| 386 | Myelitis, Transverse | 3.6% |
| 387 | Anemia, Sickle Cell | 3.6% |
| 388 | Thalassemia | 3.6% |
| 389 | Anemia, Neonatal | 3.4% |
| 390 | Ear Neoplasms | 3.4% |
| 391 | Eyelid Neoplasms | 3.4% |
| 392 | Leukocytosis | 3.4% |
| 393 | Lung Neoplasms | 3.4% |
| 394 | Paraproteinemias | 3.4% |
| 395 | Pelger-Huet Anomaly | 3.4% |
| 396 | Pleural Neoplasms | 3.4% |
| 397 | Pleocytosis | 3.4% |
| 398 | Primary Myelofibrosis | 3.4% |
| 399 | Agranulocytosis | 3.4% |
| 400 | Anemia, Megaloblastic | 3.4% |
| 401 | Lymphocytosis | 3.4% |
| 402 | Myelofibrosis | 3.4% |
| 403 | Myeloid Metaplasia | 3.4% |
| 404 | Hypoalbuminemia | 3.4% |
| 405 | Hypereosinophilic syndrome | 3.4% |
| 406 | bone marrow fibrosis | 3.4% |
| 407 | Thrombotic Microangiopathies | 3.4% |
| 408 | Cell Transformation, Viral | 3.4% |
| 409 | Brain Neoplasms | 3.4% |
| 410 | Salivary Gland Neoplasms | 3.4% |
| 411 | Spinal Cord Neoplasms | 3.4% |
| 412 | Tongue Neoplasms | 3.4% |
| 413 | Pituitary Adenoma | 3.3% |
| 414 | Pituitary Neoplasms | 3.3% |
| 415 | Cryoglobulinemia | 3.3% |
| 416 | Monoclonal Gammopathy of Undetermined Significance | 3.3% |
| 417 | Uterine Neoplasms | 3.3% |
| 418 | Vaginal Neoplasms | 3.3% |
| 419 | Vulvar Neoplasms | 3.3% |
| 420 | Uterine Cancer | 3.3% |
| 421 | Fallopian Tube Neoplasms | 3.3% |
| 422 | Autoimmune thrombocytopenia | 3.2% |
| 423 | Immune thrombocytopenic purpura | 3.2% |
| 424 | Bronchial Neoplasms | 3.1% |
| 425 | Multiple Pulmonary Nodules | 3% |
| 426 | Hemolytic-Uremic Syndrome | 3% |
| 427 | Supratentorial Neoplasms | 3% |
| 428 | Endometrial Neoplasms | 3% |
| 429 | Pharyngeal Neoplasms | 2.9% |
| 430 | ovarian neoplasm | 2.9% |
| 431 | Sickle Cell Trait | 2.9% |
| 432 | Purpura, Hyperglobulinemic | 2.8% |
| 433 | Central Nervous System Cysts | 2.8% |
| 434 | Bile Duct Neoplasms | 2.8% |
| 435 | gallbladder neoplasm | 2.8% |
| 436 | Intestinal Neoplasms | 2.8% |
| 437 | Neutropenia | 2.8% |
| 438 | Penile Neoplasms | 2.8% |
| 439 | Prostatic Neoplasms | 2.8% |
| 440 | Stomach Neoplasms | 2.8% |
| 441 | Brain Stem Neoplasms | 2.8% |
| 442 | Hypergammaglobulinemia | 2.8% |
| 443 | Fanconi Anemia | 2.8% |
| 444 | Transfusion-Related Acute Lung Injury | 2.7% |
| 445 | Ecchymosis | 2.7% |
| 446 | Petechiae | 2.7% |
| 447 | Purpura | 2.7% |
| 448 | Xeroderma Pigmentosum | 2.7% |
| 449 | Choroid Plexus Papilloma | 2.7% |
| 450 | Thrombocytopenic purpura | 2.7% |
| 451 | Atypical Hemolytic Uremic Syndrome | 2.6% |
| 452 | Lymphopenia | 2.6% |
| 453 | Job Syndrome | 2.5% |
| 454 | Hypopharyngeal Neoplasms | 2.5% |
| 455 | Pleural Effusion, Malignant | 2.5% |
| 456 | Hypopharyngeal Cancer | 2.5% |
| 457 | Febrile Neutropenia | 2.5% |
| 458 | Laryngeal neoplasm | 2.5% |
| 459 | Parotid Neoplasms | 2.5% |
| 460 | Prostatic Neoplasms, Castration-Resistant | 2.5% |
| 461 | Nelson Syndrome | 2.5% |
| 462 | Hydrops Fetalis | 2.4% |
| 463 | Bladder Neoplasm | 2.4% |
| 464 | Kidney Neoplasm | 2.4% |
| 465 | Ureteral Neoplasms | 2.4% |
| 466 | Urethral Neoplasms | 2.4% |
| 467 | Tonsillar Neoplasms | 2.3% |
| 468 | Cerebellar Neoplasms | 2.3% |
| 469 | Zollinger-Ellison syndrome | 2.2% |
| 470 | Acute Chest Syndrome | 2.2% |
| 471 | Pulmonary Eosinophilia | 2.1% |
| 472 | Eosinophilic Pneumonia | 2.1% |
| 473 | Cecal Neoplasms | 2.1% |
| 474 | Duodenal Neoplasms | 2.1% |
| 475 | Waterhouse-Friderichsen Syndrome | 2.1% |
| 476 | Anemia, Pernicious | 2.1% |
| 477 | Eosinophilia-Myalgia Syndrome | 2% |
| 478 | Chronic granulomatous disease | 2% |
| 479 | Shwartzman Phenomenon | 2% |
| 480 | Scurvy | 2% |
| 481 | Radicular Cyst | 2% |
| 482 | Purpura Fulminans | 2% |
| 483 | Appendiceal Neoplasms | 2% |
| 484 | Colonic Neoplasms | 2% |
| 485 | Rectal Neoplasms | 2% |
| 486 | Nasopharyngeal Neoplasms | 1.9% |
| 487 | Colorectal Neoplasms | 1.8% |
| 488 | Kernicterus | 1.7% |
| 489 | Paranasal Sinus Neoplasms | 1.7% |
| 490 | POEMS Syndrome | 1.7% |
| 491 | Anus Neoplasms | 1.7% |
| 492 | Sigmoid Neoplasms | 1.7% |
| 493 | Maxillary Sinus Neoplasms | 1.5% |
| 494 | Pseudoxanthoma Elasticum | 1.1% |